1. Home
  2. ATAI vs OBK Comparison

ATAI vs OBK Comparison

Compare ATAI & OBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATAI
  • OBK
  • Stock Information
  • Founded
  • ATAI 2018
  • OBK 1912
  • Country
  • ATAI Netherlands
  • OBK United States
  • Employees
  • ATAI N/A
  • OBK N/A
  • Industry
  • ATAI Biotechnology: Pharmaceutical Preparations
  • OBK Major Banks
  • Sector
  • ATAI Health Care
  • OBK Finance
  • Exchange
  • ATAI Nasdaq
  • OBK Nasdaq
  • Market Cap
  • ATAI 1.1B
  • OBK 1.0B
  • IPO Year
  • ATAI 2021
  • OBK 2018
  • Fundamental
  • Price
  • ATAI $5.84
  • OBK $34.66
  • Analyst Decision
  • ATAI Strong Buy
  • OBK Strong Buy
  • Analyst Count
  • ATAI 5
  • OBK 7
  • Target Price
  • ATAI $14.00
  • OBK $43.14
  • AVG Volume (30 Days)
  • ATAI 7.0M
  • OBK 180.9K
  • Earning Date
  • ATAI 11-14-2025
  • OBK 10-22-2025
  • Dividend Yield
  • ATAI N/A
  • OBK 1.73%
  • EPS Growth
  • ATAI N/A
  • OBK N/A
  • EPS
  • ATAI N/A
  • OBK 1.91
  • Revenue
  • ATAI $2,309,000.00
  • OBK $327,688,000.00
  • Revenue This Year
  • ATAI $736.04
  • OBK $12.91
  • Revenue Next Year
  • ATAI N/A
  • OBK $7.10
  • P/E Ratio
  • ATAI N/A
  • OBK $18.14
  • Revenue Growth
  • ATAI 510.85
  • OBK N/A
  • 52 Week Low
  • ATAI $1.04
  • OBK $28.80
  • 52 Week High
  • ATAI $6.75
  • OBK $41.17
  • Technical
  • Relative Strength Index (RSI)
  • ATAI 54.11
  • OBK 50.88
  • Support Level
  • ATAI $5.50
  • OBK $34.04
  • Resistance Level
  • ATAI $6.23
  • OBK $35.37
  • Average True Range (ATR)
  • ATAI 0.47
  • OBK 1.02
  • MACD
  • ATAI -0.05
  • OBK 0.23
  • Stochastic Oscillator
  • ATAI 36.10
  • OBK 78.12

About ATAI ATAI Life Sciences N.V.

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

About OBK Origin Bancorp Inc.

Origin Bancorp Inc is a financial holding company. The bank provides a broad range of financial services to businesses, municipalities, high-net-worth individuals, and retail clients. The bank principally operates in one business segment, community banking. The bank is engaged in attracting deposits from individuals and businesses and using these deposits and borrowed funds to originate commercial, residential mortgage, construction, and consumer loans. The bank generates the majority of its revenue from interest earned on loans and investments, service charges, and fees on deposit accounts.

Share on Social Networks: